Tradestie Institutional Equity Comparison Engine

ANRO vs SGMO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ANRO Overall Edge

ANRO Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alto Neuroscience Inc. (ANRO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SGMO counters with relative strength in Valuation. Fundamentally, ANRO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SGMO at 0.4x Forward P/E and -175.5% operating margin (+88.4% YoY). In options structure, ANRO sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against SGMO sits in UNCLASSIFIED (71st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SGMO
ANRO N/M vs SGMO 0.4x Fwd P/E
Growth & Margin Winner ANRO
Op Margin 0.0% vs -175.5% ยท YoY +0.0% vs +88.4%
Momentum & Technical Winner ANRO
1Y +144.7% vs -76.0% ยท 52W Pos 64% vs 9%
Options & Structure Winner ANRO
CONSOLIDATION (8th %ile IV) vs UNCLASSIFIED (71st %ile IV)
ANRO NYSE
Alto Neuroscience Inc.
Pharmaceutical Preparations
$27.77
-5.99% 1D
Market Cap $1.2B
1M Return +26.57%
1Y Return +144.67%
Forward P/E N/M
Unified AI Score
29.3 / 100 SELL
Tech 50.0 Fund 34.0 Flow 65.0 Mom 40.0
SGMO NASDAQ
Sangamo Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.18
+31.56% 1D
Market Cap $55.9M
1M Return -40.82%
1Y Return -76.04%
Forward P/E 0.4x
Unified AI Score
52.0 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ANRO +144.67% SGMO -76.04% Spread: +182.4 pp (ANRO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ANRO TTM Op. Margin: 0.0% SGMO TTM Op. Margin: -175.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANRO vs SGMO. Trailing 12-month operating profitability (ANRO 0.0% vs SGMO -175.5%) and valuation multiples (ANRO N/M vs SGMO 0.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ANRO (5) vs SGMO (4)
Institutional Metric ANRO SGMO Criterion Row Winner
Market Capitalization Scale $1.2B $55.9M Larger Scale ANRO
Trailing P/E Ratio Valuation N/M 0.4x Lower Multiple SGMO
Forward P/E Ratio Valuation N/M 0.4x Lower Multiple SGMO
Revenue Growth (YoY) Growth +0.0% +88.4% Higher Growth SGMO
Operating Margin (TTM) Profitability 0.0% -175.5% Higher Margin ANRO
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -46.7% -2891.8% Higher ROE ANRO
52-Week Range Position Momentum 64% ($11โ€“$37) 9% ($0โ€“$1) Stronger Trend ANRO
Beta / 30D Volatility Risk Regime 1.95ฮฒ ยท 89% Vol 1.49ฮฒ ยท 206% Vol Lower Realized Risk ANRO
Unified Institutional Score Composite Signal 29.3 / 100 (SELL) 52.0 / 100 (HOLD) Higher Composite SGMO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ANRO vs SGMO Buy Guide
ANRO CONSOLIDATION
57d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ANRO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SGMO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 71st %ile
IV Regime Elevated (60thโ€“80th %ile)
Live SGMO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ANRO nor SGMO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.